Journal article · 2024 · Open access

Structure-based drug design with equivariant diffusion models

Arne Schneuing, Charles Bonner Harris, Yuanqi Du, Kieran Didi, Arian R. Jamasb, Ilia Igashov, Weitao Du, Carla Pedro Gomes, Tom L. Blundell, Píetro Lió, Max Welling, Michael M. Bronstein and 1 more

Nature Computational Science, 4(12), 899–909 · Published 9 December 2024 · DOI 10.1038/s43588-024-00737-x

Open full textCite this paper

In brief

“Structure-based drug design with equivariant diffusion models” is a 2024 journal article by Arne Schneuing and 12 co-authors, published in Nature Computational Science. OpenAlex counts 542 citations as of 16 November 2026, which puts it in the top 7% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Nature Computational Science.

Citations
542
Most cited in
2026 (235)
Field-weighted impact
64.19
References
76
Authors
13

Abstract

Structure-based drug design (SBDD) aims to design small-molecule ligands that bind with high affinity and specificity to pre-determined protein targets. Generative SBDD methods leverage structural data of drugs with their protein targets to propose new drug candidates. However, most existing methods focus exclusively on bottom-up de novo design of compounds or tackle other drug development challenges with task-specific models. The latter requires curation of suitable datasets, careful engineering of the models and retraining from scratch for each task. Here we show how a single pretrained diffusion model can be applied to a broader range of problems, such as off-the-shelf property optimization, explicit negative design and partial molecular design with inpainting. We formulate SBDD as a three-dimensional conditional generation problem and present DiffSBDD, an SE(3)-equivariant diffusion model that generates novel ligands conditioned on protein pockets. Furthermore, we show how additional constraints can be used to improve the generated drug candidates according to a variety of computational metrics.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Schneuing, A., Harris, C. B., Du, Y., Didi, K., Jamasb, A. R., Igashov, I., Du, W., Gomes, C. P., Blundell, T. L., Lió, P., Welling, M., Bronstein, M. M., & Correia, B. E. (2024). Structure-based drug design with equivariant diffusion models. Nature Computational Science, 4(12), 899–909. https://doi.org/10.1038/s43588-024-00737-x

MLA 9

Schneuing, Arne, et al. “Structure-based drug design with equivariant diffusion models.” Nature Computational Science, vol. 4, no. 12, 2024, pp. 899–909. https://doi.org/10.1038/s43588-024-00737-x.

Chicago

Schneuing, Arne, Charles Bonner Harris, Yuanqi Du, Kieran Didi, Arian R. Jamasb, Ilia Igashov, Weitao Du, et al. 2024. “Structure-based drug design with equivariant diffusion models.” Nature Computational Science 4 (12): 899–909. https://doi.org/10.1038/s43588-024-00737-x.

Harvard

Schneuing, A. et al. (2024) ‘Structure-based drug design with equivariant diffusion models’, Nature Computational Science, 4(12), pp. 899–909. doi:10.1038/s43588-024-00737-x.

IEEE

A. Schneuing et al., “Structure-based drug design with equivariant diffusion models,” Nature Computational Science, vol. 4, no. 12, pp. 899–909, 2024, doi: 10.1038/s43588-024-00737-x.

BibTeX

@article{schneuing2024structure,
  title     = {{Structure-based drug design with equivariant diffusion models}},
  author    = {Schneuing, Arne and Harris, Charles Bonner and Du, Yuanqi and Didi, Kieran and Jamasb, Arian R. and Igashov, Ilia and Du, Weitao and Gomes, Carla Pedro and Blundell, Tom L. and Lió, Píetro and Welling, Max and Bronstein, Michael M. and Correia, Bruno E.},
  journal   = {Nature Computational Science},
  year      = {2024},
  volume    = {4},
  number    = {12},
  pages     = {899--909},
  doi       = {10.1038/s43588-024-00737-x},
  url       = {https://doi.org/10.1038/s43588-024-00737-x}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202222
20235151
2024113113
2025141141
2026235235

Its field-weighted citation impact is 64.19: it has been cited 64.19 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • structure-based drug design
  • SE(3) equivariance
  • protein-ligand binding
  • ligand generation
  • protein pockets
  • property optimization
  • inpainting
  • pre-trained diffusion models

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Schneuing, A., Harris, C. B., Du, Y., Didi, K., Jamasb, A. R., Igashov, I., Du, W., Gomes, C. P., Blundell, T. L., Lió, P., Welling, M., Bronstein, M. M., & Correia, B. E. (2024). Structure-based drug design with equivariant diffusion models. Nature Computational Science, 4(12), 899–909. https://doi.org/10.1038/s43588-024-00737-x

How many times has this paper been cited?

542 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Nature Computational Science: sign in and open the full text from this page.

Who wrote this paper?

Arne Schneuing, Charles Bonner Harris, Yuanqi Du, Kieran Didi, Arian R. Jamasb, Ilia Igashov, Weitao Du, Carla Pedro Gomes, Tom L. Blundell, Píetro Lió, Max Welling, Michael M. Bronstein and 1 more.

What is the DOI of this paper?

10.1038/s43588-024-00737-x, permanently at https://doi.org/10.1038/s43588-024-00737-x. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.